API Group backed Thyrocare Technologies Limited, a pan-India diagnostic laboratory services provider, has announced the appointment of Rahul Guha as the company's Managing Director and Chief Executive Officer w.e.f May 2022.
A graduate of IIM-B, Rahul Guha joins API Group to head its Diagnostics Business. Rahul has spent almost 17 years at Boston Consulting Group (BCG) where he has led the Health Care & Life Sciences practice.
On the appointment - Siddharth Shah, MD and CEO at API Holdings had to say, "As we strive towards making healthcare affordable and accessible to every single Indian, we are extremely excited to have Rahul join us in our mission. I am elated to share that Rahul will be leading Thyrocare as its MD and CEO and will also be responsible for diagnostics as a segment at the group level. His invaluable experience of over two decades in healthcare will help us scale our diagnostics franchise."
Prior to joining BCG, Rahul has been the co-founder and CEO of Nautilus Software and the Chief Technology Office (CTO) at ValuePay.com where he was responsible for product development in the US Market. He has extensive project experience in MedTech and HealthTech and has worked closely with multiple startups on their digital incubation. He has been an active contributor to the pharma sector and has over 2 decades of experience.
On this announcement, Rahul Guha had to say, "I am very excited to join the phenomenal team at API Group and look forward to delivering a transformative customer experience to diagnostic users which will not only leverage the digital capabilities but also conjoin the extensive network of Thyrocare."
Shares of Thyrocare Technologies Limited was last trading in BSE at Rs. 982.05 as compared to the previous close of Rs. 969.50. The total number of shares traded during the day was 10233 in over 1328 trades.
The stock hit an intraday high of Rs. 1006.90 and intraday low of 955.55. The net turnover during the day was Rs. 10088260.00.